Leitlinie
Immunotoxicity Evaluation and Guidelines for Drug Approval in Korea
Drug Information Journal · 2000
DOI: 10.1177/009286150003400103 ↗Kurz gefasst
Leitlinie in der Zeitschrift Drug Information Journal, 2000. Verfasst von Young-Ok Kim und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kim, Y., Chung, H., Kil, K., Park, J., Kim, D., & Cho, D. (2000). Immunotoxicity Evaluation and Guidelines for Drug Approval in Korea. Drug Information Journal. https://doi.org/10.1177/009286150003400103
Vancouver
Kim Y, Chung H, Kil K, Park J, Kim D, Cho D. Immunotoxicity Evaluation and Guidelines for Drug Approval in Korea. Drug Information Journal. 2000. doi:10.1177/009286150003400103
BibTeX
@article{Kim2000,
author = {Kim, Young-Ok and Chung, Hyejoo and Kil, Kwang-Sup and Park, Jae-Hyun and Kim, Dong-Sup and Cho, Dae-Hyun},
title = {Immunotoxicity Evaluation and Guidelines for Drug Approval in Korea},
journal = {Drug Information Journal},
year = {2000},
doi = {10.1177/009286150003400103}
}
EUVIMED